Related Experiment Video
Updated: Jul 19, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
alpha-Defensin: link between inflammation and atherosclerosis
Hisham Nassar1, Ehud Lavi, Sa'ed Akkawi
1Department of Cardiology, Hadassah Medical Center, Jerusalem, IL 91120, Israel.
Insights
Alpha-defensins, found in atherosclerotic arteries, are strong predictors of coronary artery disease (CAD) severity in men. This finding links neutrophil activation to atherosclerosis progression, offering a new risk assessment approach.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- Inflammation markers predict thrombotic cardiovascular events in atherosclerosis patients.
- The role of vascular inflammation in atherothrombotic disease is not fully understood.
- Human neutrophil peptides 1-3 (alpha-defensins) are present in atherosclerotic arteries and affect LDL metabolism and fibrinolysis.
Purpose of the Study:
- To investigate if alpha-defensins are risk factors for the presence and severity of atherosclerosis.
- To determine the correlation between alpha-defensin deposition in skin and coronary artery disease (CAD) severity.
Main Methods:
- Alpha-defensin levels were measured in skin biopsies from 53 male patients undergoing coronary artery catheterization.
- Established cardiovascular risk factors were concurrently measured.
- Correlation and regression analyses were used to examine the relationship between skin alpha-defensin and CAD severity.
Main Results:
- A significant correlation was found between skin alpha-defensin levels and CAD severity (R=0.40, p=0.003).
- Skin alpha-defensin independently predicted CAD severity in multiple regression analysis (F=4.68, p=0.035).
- Logistic regression confirmed skin alpha-defensin as an independent predictor of CAD likelihood (p=0.016, odds ratio 5.97).
Conclusions:
- Skin alpha-defensin deposition is a significant independent predictor of CAD in men.
- These findings suggest a connection between neutrophil activation and atherosclerosis progression.
- Alpha-defensin measurement may offer a novel method for assessing CAD risk factors.
Background:
Several markers of inflammation predict the risk of thrombotic cardiovascular events in patients with atherosclerosis. However, the mechanism by which vascular inflammation promotes atherothrombotic disease is incompletely understood. Human neutrophil peptides 1-3, also known as alpha-defensins, are found in human atherosclerotic arteries, inhibit LDL metabolism and fibrinolysis and promote Lp(a) binding. We asked, therefore, if alpha-defensins are risk factors for the presence and severity of atherosclerosis.
Methods:
alpha-Defensin was measured in skin biopsies taken from 53 male patients (age 58.7+/-11.3 years, mean+/-S.D.) immediately prior to coronary artery catheterization. Other established risk factors were measured concurrently. The correlation between alpha-defensin deposition in the skin and the severity of the coronary artery disease (CAD) was examined.
Results:
A statistically significant correlation was observed between the amount of alpha-defensin in skin and the severity of CAD (R=0.40, p=0.003). Multiple regression analysis showed that skin alpha-defensin is an independent predictor for CAD severity (F=4.68, p=0.035). Logistic regression analysis confirmed that skin alpha-defensin independently predicted the likelihood for CAD (p=0.016, odds estimate 5.97, 95% CL 1.4-24.2).
Conclusions:
The deposition of alpha-defensin in the skin is a strong independent predictor of CAD in men. These results suggest a link between neutrophil activation and progression of atherosclerosis and provide a novel approach to assessment of risk factors for CAD.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
